Bristol-Myers Squibb Co. BDR | |
Stock Exchange | Brazilian Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Bristol-Myers Squibb Co. | |
Stock Exchange | Xetra Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.63 B |
Public Float |
1.63 B |
Bristol-Myers Squibb Co. | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN60.95 |
Market Cap |
MXN1.44 T |
Shares Outstanding |
1.63 B |
Public Float |
1.63 B |
Bristol-Myers Squibb Co. | |
Stock Exchange | New York Stock Exchange |
EPS |
$3.16 |
Market Cap |
$75.06 B |
Shares Outstanding |
1.64 B |
Public Float |
1.63 B |
Bristol-Myers Squibb Co. | |
Stock Exchange | SIX Swiss Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
1.63 B |
Public Float |
1.63 B |
Address |
430 East 29th Street New York New York 10154 United States |
Employees | - |
Website | http://www.bms.com |
Updated | 07/08/2019 |
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |